Your browser doesn't support javascript.
Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
Sato, Ryoko.
  • Sato R; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Department of Global Health and Population, 90 Smith St, Boston 02120, MA USA. Electronic address: rsato@hsph.harvard.edu.
Vaccine ; 41(17): 2749-2753, 2023 04 24.
Article in English | MEDLINE | ID: covidwho-2279934
ABSTRACT

INTRODUCTION:

While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This study examined the extent and trend of vaccine hesitancy in Nigeria.

METHODS:

The COVID-19 National Longitudinal Phone Survey conducted between 2020 and 2021 was used for the analysis. The extent and trend of vaccine hesitancy across different zones within Nigeria, over time, as well as reasons of the hesitancy were evaluated.

RESULTS:

Vaccine hesitancy was more prevalent in southern zones, which on average have better socioeconomic status than northern zones. Overtime, vaccine hesitancy became more prevalent, and respondents became more resistant to the COVID-19 vaccine across the country.

CONCLUSION:

While the nature of interventions to improve the uptake of COVID-19 vaccine should differ by regions due to differential barriers to vaccination, it might be important to prebunk and debunk any misinformation related to COVID-19 vaccine to mitigate the vaccine hesitancy across the country.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Vaccine Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Vaccine Year: 2023 Document Type: Article